You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Liver X receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liver X Receptor asNovel Therapeutic Target in Diabetic

Recruiting
  • Diabetic Retinopathy
  • blood draw
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 13, 2021

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022

Liver Cirrhosis, Non-Alcoholic Fatty Liver Disease, Hepatocellular Carcinoma Trial in Roma (Handgrip strength test, total body

Recruiting
  • Liver Cirrhosis
  • +2 more
  • Handgrip strength test
  • +2 more
  • Roma, RM, Italy
    CEMAD
Oct 20, 2023

Liver Cancer Trial in Utrecht (IXSI)

Completed
  • Liver Cancer
  • IXSI
  • Utrecht, Netherlands
    UMC Utrecht
Aug 24, 2023

Obesity, Liver Diseases, Liver Fibrosis Trial in Boston (ESG, GLP1-RA)

Not yet recruiting
  • Obesity
  • +16 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 14, 2023

Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in

Not yet recruiting
  • Pancreatic Neuroendocrine Tumor
  • Pancreas Cancer
  • cytoreductive surgery
  • +2 more
  • Chicago, Illinois
    The University of Chicago
Nov 8, 2022

Portal Hypertension Trial in Nanjing (Endoscopy+NSBBs, Transjugular intrahepatic portosystemic shunt)

Recruiting
  • Portal Hypertension
  • Endoscopy+NSBBs
  • Transjugular intrahepatic portosystemic shunt
  • Nanjing, Jiangsu, China
    Nanjing Drum Tower Hospital
Aug 22, 2023

Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

Not yet recruiting
  • Digestive System Neuroendocrine Tumor G1
  • +5 more
  • Tumor Debulking
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 23, 2023

Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)

Recruiting
  • Liver Cell Carcinoma
  • +7 more
  • CATCH T cells
  • +2 more
  • Houston, Texas
    Houston Methodist Hospital
Dec 19, 2022

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • +2 more
  • Biopsy
  • +11 more
  • Duarte, California
    City of Hope Medical Center
Aug 7, 2023

Liver Transplant; Complications Trial in Warsaw (TachoSil)

Recruiting
  • Liver Transplant; Complications
  • Warsaw, Mazovian Voivodeship, Poland
    Department of General Transplant and Liver Surgery
Nov 3, 2023

Cough Trial (device, diagnostic test, procedure)

Not yet recruiting
  • Cough
  • Adenosine triphosphate (ATP) solution inhalation from nebuliser
  • +7 more
  • (no location specified)
Jan 26, 2023

Glioblastoma Trial (PET imaging)

Not yet recruiting
  • Glioblastoma
  • PET imaging
  • (no location specified)
Feb 23, 2023

Non-alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Trial in Chandler, Peoria

Completed
  • Non-alcoholic Steatohepatitis
  • +2 more
  • BT-NCBT-00X
  • Chandler, Arizona
  • +1 more
Dec 12, 2022

Fibrinogen and Intraoperative Bleeding in Liver Transplant

Completed
  • End Stage Liver DIsease
  • Liver Transplant; Complications
    • Montréal, Quebec, Canada
      Centre Hospitalier de l'Université de Montréal (CHUM)
    Nov 24, 2022

    Steatohepatitis, Nonalcoholic Trial in Shibin Al Kawm (Control group, Montelukast group)

    Completed
    • Steatohepatitis, Nonalcoholic
    • Control group
    • Montelukast group
    • Shibīn Al Kawm, Menoufia, Egypt
      Faculty of Medicine
    Mar 15, 2022

    Wilsons Disease Trial in Aarhus (Fibroscan, Ultrasound, Galactose)

    Completed
    • Wilsons Disease
    • Fibroscan
    • +4 more
    • Aarhus, Denmark
      Department of Hepatology and Gastroenterology, Aarhus University
    Nov 1, 2022

    Nonalcoholic Steatohepatitis

    Recruiting
    • Nonalcoholic Fatty Liver Disease (NAFLD)
    • Nonalcoholic Steatohepatitis (NASH)
    • Acoustic radiation force impulse (ARFI), magnetic resonance elastography (MRE)
    • Montréal, Quebec, Canada
      Centre Hospitalier de l'Université de Montréal
    Nov 11, 2022

    Hepatocellular Carcinoma Trial in Guangzhou (TCR-T, No intervention and TCR-T (at crossover))

    Completed
    • Hepatocellular Carcinoma
    • TCR-T
    • No intervention and TCR-T (at crossover)
    • Guangzhou, Guangdong, China
      The First Affiliated Hospital, Sun-Yat Sen University
    Jun 27, 2022

    Type 2 Diabetes Trial in Uppsala (SAR425899, [68Ga] Ga-DO3A-VS-Cys40-Tuna-2 (glucagon receptor tracer), [68Ga]

    Completed
    • Type 2 Diabetes Mellitus
    • Uppsala, Sweden
      Investigational Site Number 7520001
    Apr 21, 2022

    Cirrhotic Patients Undergoing Liver Transplantation

    Completed
    • Liver Transplantation
    • +3 more
      • Montréal, Quebec, Canada
        Centre Hospitalier de l'Université de Montréal (CHUM)
      Jul 21, 2022

      Human Immunodeficiency Virus I Infection Trial in Lyon (Blood collection.)

      Not yet recruiting
      • Human Immunodeficiency Virus I Infection
      • Blood collection.
      • Lyon, France
        Service des maladies infectieuses et tropicales Hôpital de la Cr
      Jan 21, 2022

      Effect of SARS-CoV-2 Vaccination in Liver Transplant Recipients

      Completed
      • SARS-CoV-2 Vaccination
      • Liver Transplantation
      • Immunoassay, by ECLIA, for the quantitative in vitro determination of antibodies (including IgG) to the SARS - CoV - 2 spike protein (S) anti-RBD (receptor-binding domain) in serum and plasma samples.
      • Roma, Italy
        Policlinico Tor Vergata
      Aug 3, 2022

      Failure in Metastatic Colorectal Cancer Patients

      Recruiting
      • Colorectal Cancer Metastatic
        • Montreal, Quebec, Canada
          Centre hospitalier de l'Université de Montréal (CHUM)
        Nov 11, 2022